Creative Biolabs’ Accomplished the Fantastic Journey in PEGS

May 25 16:54 2023
Creative Biolabs participated in the PEGS Boston Summit 2023 with a brand new package of one-stop drug discovery solutions.

New York, USA – May 25, 2023 – The 2023 PEGS Summit, held from May 15 to May 19, attracted hundreds of scientists working in the biotechnology and pharmaceutical industries to network and share ideas and opportunities to advance research and innovations. Creative Biolabs is one of the returned exhibitors and was represented by a group of senior scientists who shared advances in their solutions and sought new partnership opportunities.

During the four-day campaign, the delegates presented their specialties in antibody-based drug discovery, from target identification all the way to IND-enabling programs, and emphasized their drug delivery strategies, including liposome development service-manipulate liposomes based on their biocompatibility and the easy control of liposomes to load a wide range of drugs, DNA, and diagnostic agents.

“Our liposome development strategies to boost drug delivery include liposome formulation design, liposome encapsulation, and liposome-drug complex analysis and characterization,” summarized one of the delegates, “and we have various novel liposome formulations, such as immunoliposomes, proteoliposomes, magnetic liposomes, fluorescent liposomes, and pH-sensitive liposomes. Specifically, we’ve recruited LNP development, which is emerging and has gained the first approval in 2018, but has witnessed a dramatic climb in research interest these years, driven by the urgent need for a safe and efficient delivery vehicle for genetic medicines.”

Another strategy for drug delivery involves the cell communicator, exosomes. The experts develop and transform exosomes for research use.

“Our team provides comprehensive engineering exosome construction services, from exosome isolation and identification to in vivo and in vitro functional research. We also offer systematic exosome analysis technology to understand the content of protein, lipid, and RNA molecules in exosomes through high-throughput multi-omics solutions to design effective exosome-based drug carriers.”

“Take the exosome cargo loading strategy for example,” added the delegate, “during the conference, we had conversations with our clients about what substances can be loaded and what strategies are adopted.”

As the curtain fell down for the PEGS 2023, these scientists started to prepare for their forthcoming exhibition without a single halt.

“There are chances to meet face-to-face in June,” said the delegate, “including the forthcoming CSHL stem cell symposium from May 31 to June 4 and the 2023 BIO International Convention from June 5 to June 8. We look forward to old and new friends visiting our booth.”

Learn more at: https://www.creative-biolabs.com

About

Over the course of more than a decade, Creative Biolabs has been offering resources that facilitate drug discovery. The company was established by a team of scientists who have the common goal of enhancing precision medicine through the use of cutting-edge technology. These researchers are firm believers that new ideas are the driving force behind advancements, and they keep a careful eye on the development in various fields of technology. To this end, they regularly participate in industry events and showcase their capabilities through intensive exhibitions and presentations.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com

  Categories:
view more articles

About Article Author